Advertisement
Advertisement

HRMY

HRMY logo

Harmony Biosciences Holdings Inc

34.24
USD
+0.35
+1.03%
Dec 20, 15:59 UTC -5
Closed
...

Harmony Biosciences Holdings Inc Profile

About

Harmony Biosciences Holdings Inc.is a pharmaceutical company. It engages in developing and commercializing therapies for rare neurological disorders. Harmony Biosciences Holdings Inc.is based in Plymouth Meeting, Pennsylvania.

Info & Links

CEO

Jeffrey M. Dayno

Headquarters

630 W. Germantown Pike, Suite 215
Plymouth Meeting, PA 19462, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

35

Employees

246

Harmony Biosciences Holdings Inc Statistics

Valuation Measures

Market Capitalization2

1.95B

Enterprise Value

1.75B

Enterprise Value/EBITDA(ttm)

8.84

Price to Earnings Ratio(ttm)

16.06

Price to Sales(ttm)

2.83

Price to Book(mrq)

3.24

Price to Cash(ytd)

12.99

Profitability

Gross Margin(ttm)

78.75%

Operating Margin(ttm)

17.98%

Profit Margin(ttm)

18.02%

Return on Equity(ttm)

23.16%

Return on Invested Capital(ttm)

17.33%

Return on Assets(ttm)

14.24%

Income Statement

Revenue(ttm)

681.88M

Revenue Per Share(ttm)

11.96

Gross Profit(ttm)

536.32M

EBITDA(ttm)3

197.83M

Net Income Available to Common(ttm)

122.63M

Diluted EPS(ttm)

2.11

Share Statistics

Beta (5Y Monthly)

0.79

52-Week Change

9.57%

S&P 500 52-Week Change

24.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

57.03M

Dividend Yield

0.00%

Float4

39.47M

% Held by Insiders

30.80%

% Held by Institutions

86.23%

Balance Sheet

Total Cash(mrq)

410.48M

Total Cash Per Share(mrq)

7.20

Total Debt(mrq)

182.85M

Total Debt/Equity(mrq)

30.64%

Current Ratio(mrq)

3.24%

Quick Ratio(mrq)

3.20%

Book Value Per Share(mrq)

10.46

Cash Flow

Operating Cash Flow Per Share(ytd)

2.48

Free Cash Flow(ytd)

143.62M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement